Posted

PREempt Efficacy Against SARS-CoV-2, the Virus Which Causes COVID-19 Disease

Cover Image for PREempt Efficacy Against SARS-CoV-2, the Virus Which Causes COVID-19 Disease

Trusted in times of crisis, PREempt™, formulated with Accelerated Hydrogen Peroxide® is approved for use against SARS-CoV-2, the virus that causes COVID-19 when used in accordance with the directions for use against Poliovirus type 1.  For PREempt™ Concentrate use a 1:40 dilution and contact time 5 minutes and a contact time of 3 minutes for PREempt™ RTU and Wipes.

For further information, please review our formal press release below.


Related Posts

Cover Image for Re:Preempt (Canada) efficacy against Monkeypox Virus (MPV)

Re:Preempt (Canada) efficacy against Monkeypox Virus (MPV)

To Whom it May Concern, In cases of emerging viral pathogens such as Monkeypox Virus (MPV), when there is no test that can be conducted to validate the efficacy of a disinfectant, Health Canada utilizes its policy for claims against emerging viral pathogens to determine the expected efficacy of a disinfectant against an emerging virus. […]

READ MORE
Cover Image for Re: PREempt efficacy against SARS-CoV-2, the virus which causes COVID-19 disease

Re: PREempt efficacy against SARS-CoV-2, the virus which causes COVID-19 disease

Dear Sir or Madam, In cases of emerging viral pathogens like SARS-CoV-2, the virus that causes COVID-19, when there is no test that can be conducted to validate the efficacy of a disinfectant against an emerging viral pathogen, Health Canada utilizes the Broad Spectrum Virucide claim to determine the expected efficacy of a disinfectant against […]

READ MORE